{"transactions":[{"id":345524,"issuer":{"id":3203,"kind":"organization","name":"Veralto Corp"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T00:10:52.000Z","date":"2023-09-30","kind":"other","planned":false,"acquired":false,"shares":246291342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form relates to the distribution on September 30, 2023 to holders of Danaher Corporation's (\"Danaher\") common stock of all of the issued and outstanding shares of common stock of Veralto Corporation (the \"Company\") held by Danaher (the \"Distribution\"). To effect the Distribution, 246,291,342 shares of Veralto common stock were distributed, by means of a pro rata dividend, to the holders of Danaher's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of Danaher)."},{"field":"shares","element":"transactionShares","label":"F2","text":"Prior to the Distribution, solely as a result of a 2,462,913.42-for-1 stock split that was effected pursuant to a Certificate of Amendment to the Certificate of Incorporation of Veralto on September 29, 2023, the 100 shares of Veralto common stock previously owned by Danaher were split into and became an aggregate of 246,291,342 shares, in a transaction exempt from reporting pursuant to Rule 16a-9 under the Securities Exchange Act of 1934."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-051257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000120919123051257/doc4.xml","form_type":"4"}},{"id":374074,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15607,"kind":"organization","name":"Danaher Innovation Center LLC","position":2,"cik":"0001868059","reported_name":"Danaher Innovation Center LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2021-06-24T20:51:32.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":542158,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Danaher Innovation Center LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":542158},"source":{"system":"sec-edgar","filing":"0001209191-21-043061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313616/000120919121043061/doc4.xml","form_type":"4"}},{"id":374073,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15607,"kind":"organization","name":"Danaher Innovation Center LLC","position":2,"cik":"0001868059","reported_name":"Danaher Innovation Center LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-06-24T20:51:32.000Z","date":"2021-06-22","kind":"exercise","acquired":false,"shares":1751999,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Danaher Innovation Center LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1751999},"source":{"system":"sec-edgar","filing":"0001209191-21-043061","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000120919121043061/doc4.xml","form_type":"4"}},{"id":374072,"issuer":{"id":15606,"kind":"organization","name":"Telesis Bio Inc.","symbol":"TBIO"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15607,"kind":"organization","name":"Danaher Innovation Center LLC","position":2,"cik":"0001868059","reported_name":"Danaher Innovation Center LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-24T20:51:32.000Z","date":"2021-06-22","kind":"exercise","acquired":true,"shares":2294157,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Danaher Innovation Center LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series A-1 Preferred Stock (collectively, the \"Preferred Stock\"), par value $0.0001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The right to convert the Preferred Stock into Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037."}],"balance_after":2294157,"source":{"system":"sec-edgar","filing":"0001209191-21-043061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000120919121043061/doc4.xml","form_type":"4"}},{"id":397890,"issuer":{"id":4007,"kind":"organization","name":"Envista Holdings Corp"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-18T13:58:42.000Z","date":"2019-12-18","kind":"other","acquired":false,"shares":127868000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Danaher Corporation (\"Danaher\") disposed of 127,868,000 shares of Issuer common stock in exchange for 22,921,984 shares of Danaher common stock pursuant to a registered exchange offer to holders of shares of Danaher common stock. The final exchange ratio was 5.5784 shares of Issuer common stock per share of Danaher common stock accepted in the exchange offer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-029511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000089924319029511/doc4.xml","form_type":"4"}},{"id":437056,"issuer":{"id":3303,"kind":"organization","name":"Fortive Corp","symbol":"FTV"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-07-05T20:34:13.000Z","date":"2016-07-02","kind":"other","acquired":false,"shares":345237561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form relates to the distribution to the Reporting Person's stockholders of shares of Issuer's common stock held by the Reporting Person, effective as of July 2, 2016 (the \"Distribution\"). To effect the Distribution, the issued and outstanding common stock of the Issuer, consisting of 100 shares of common stock prior to the Distribution, was recapitalized into 345,237,561 shares of the Issuer's common\nstock and distributed, by means of a pro rata dividend, to the holders of the Reporting Person's common stock (other than fractional shares, which will be aggregated and sold into the public market and the proceeds distributed to the stockholders of the Reporting Person)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-16-024318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000089924316024318/doc4.xml","form_type":"4"}},{"id":472680,"issuer":{"id":3488,"kind":"organization","name":"ALIGN TECHNOLOGY INC"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"COMMON STOCK","published_at":"2013-11-14T13:40:07.000Z","date":"2013-11-13","kind":"sale","acquired":false,"shares":4600000,"price":54.6,"value":251160000.0,"ownership":{"direct":true},"balance_after":3837132,"source":{"system":"sec-edgar","filing":"0001181431-13-058893","document":"rrd395388.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000118143113058893/rrd395388.xml","form_type":"4"}},{"id":511884,"issuer":{"id":16932,"kind":"organization","name":"KEITHLEY INSTRUMENTS INC","symbol":"KEI"},"owners":[{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR","position":1,"cik":"0000313616","reported_name":"DANAHER CORP /DE/","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":16933,"kind":"organization","name":"Aegean Acquisition Corp.","position":2,"cik":"0001502907","reported_name":"Aegean Acquisition Corp.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Shares","published_at":"2010-12-09T16:36:02.000Z","date":"2010-12-08","kind":"other","acquired":false,"shares":0,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed as a result of the consummation of the merger of Aegean Acquisition Corp. (\"Merger Sub\" and together with Danaher Corporation, the \"Reporting Persons\") with and into the Issuer on December 8, 2010.  In connection with the consummation of the merger, the separate corporate existence of Merger Sub thereupon ceased, and the Issuer became an indirectly wholly-owned subsidiary of Danaher."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001209191-10-059390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/54991/000120919110059390/doc4.xml","form_type":"4"}}]}